methylprednisolone hemisuccinate has been researched along with cyclosporine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (58.82) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marsh, JW; Perdrizet, GA; So, SK; White, HM; Woodle, ES | 1 |
| Cameron, R; Cattral, M; Chung, S; Elkashab, M; Greig, PD; Levy, G; Phillips, MJ; Reizig, M | 1 |
| Bachman, WR; Brennan, JK | 1 |
| De Rosa, CM; Delphin, E; Friedlander, JP; Goldstein, DJ; Mongero, LB; Oz, MC; Smith, CR | 1 |
| Guerraty, A; Hanrahan, JS; Ibrahim, H; Kirchberg, D; Mohanty, PK; Salter, D; Tolman, D | 1 |
| Levy, GA | 1 |
| Klassen, J; Scott-Douglas, N; Zimmerman, D | 1 |
| Aronson, AJ; Bartosh, S; Bruce, DS; Haas, M; Josephson, MA; Millis, JM; Newell, KA; Piper, JB; Thistlethwaite, JR; Woodle, ES | 1 |
| Morse, LS; Reed, JB; Schwab, IR | 1 |
| Chapman, W; Geevarghese, S; Helderman, JH; MacDonell, R; Payne, J; Pinson, CW; Richie, R; Van Buren, D; Wright, JK | 1 |
| Asante-Korang, A; Boucek, MM; Boucek, RJ; Cooper, D; Keehn, C; Putzer, GJ | 1 |
| Beschorner, WE; Dixon, RS; Fox, IJ; Franco, KL; Goertzen, TC; Hill, AC; Johnson, ND; Kuszynski, CA; Langnas, AN; Lechtenberg, KF; Matamoros, A; Radio, SJ; Rubocki, RJ; Shearon, CC; Sudan, DL; Thompson, SC; Yang, T | 1 |
| Acott, PD; Crocker, JF; Wong, JA | 1 |
| Konishi, H; Minouchi, T; Shibata, N; Sumi, M; Takada, K; Yamaji, A | 2 |
| Cohen, J; Gordon, B; Jhaveri, KD; Scheuer, A | 1 |
| Bass, D; Mojtahed, A; Yeh, AM | 1 |
2 trial(s) available for methylprednisolone hemisuccinate and cyclosporine
| Article | Year |
|---|---|
Incidence and patterns of rejection using different induction therapies in liver transplant recipients.
Topics: Antilymphocyte Serum; Biopsy, Needle; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Incidence; Liver Function Tests; Liver Transplantation; Male; Methylprednisolone Hemisuccinate; Muromonab-CD3; Prednisone; Retrospective Studies | 1994 |
Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
Topics: Adult; Analysis of Variance; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney Function Tests; Liver Transplantation; Methylprednisolone Hemisuccinate; Postoperative Complications; Regression Analysis; Retrospective Studies; Tacrolimus | 1998 |
15 other study(ies) available for methylprednisolone hemisuccinate and cyclosporine
| Article | Year |
|---|---|
FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
Topics: Adult; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Methylprednisolone Hemisuccinate; Middle Aged; Muromonab-CD3; Risk Factors; Tacrolimus; Time Factors | 1995 |
Refractory thrombotic thrombocytopenic purpura treated with cyclosporine.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Danazol; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukins; Methylprednisolone Hemisuccinate; Plasma Exchange; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Vincristine | 1996 |
Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation.
Topics: Adult; Aprotinin; Blood Loss, Surgical; Cardiopulmonary Bypass; Cyclosporine; Drug Administration Schedule; Erythrocyte Transfusion; Female; Heart Transplantation; Heart-Assist Devices; Humans; Hypotension; Kidney Function Tests; Male; Methylprednisolone Hemisuccinate; Middle Aged; Plasma Exchange; Platelet Transfusion; Preanesthetic Medication; Reoperation | 1996 |
Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
Topics: Adult; Analysis of Variance; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methylprednisolone Hemisuccinate; Middle Aged; Muromonab-CD3; Retrospective Studies; Transplantation, Homologous | 1996 |
Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
Topics: Administration, Oral; Alanine Transaminase; Antilymphocyte Serum; Aspartate Aminotransferases; Cyclosporine; Dosage Forms; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Methylprednisolone Hemisuccinate; Middle Aged; Prednisone | 1996 |
Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Methylprednisolone Hemisuccinate; Prednisone; Tacrolimus; Time Factors; Treatment Failure | 1996 |
Reversal of accelerated renal allograft rejection with FK 506.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies; Antilymphocyte Serum; Azathioprine; Biopsy; Cadaver; Capillaries; Complement C3; Creatinine; Cyclosporine; Fibrin; Glucocorticoids; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Male; Methylprednisolone Hemisuccinate; Neutrophils; Reoperation; Tacrolimus; Urinary Retention | 1997 |
High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet retinitis.
Topics: Acute Disease; Behcet Syndrome; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Prednisone; Retinitis; Visual Acuity; Visual Fields | 1998 |
An improved echocardiographic rejection-surveillance strategy following pediatric heart transplantation.
Topics: Age Factors; Algorithms; Azathioprine; Biopsy; Cardiac Volume; Chi-Square Distribution; Cyclosporine; Echocardiography; Echocardiography, Doppler; False Positive Reactions; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Image Processing, Computer-Assisted; Immunosuppressive Agents; Infant; Methylprednisolone Hemisuccinate; Myocardium; Population Surveillance; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Ventricular Function, Left | 2000 |
Heart xenograft survival with chimeric pig donors and modest immune suppression.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cyclosporine; Fetal Tissue Transplantation; Graft Rejection; Heart; Heart Transplantation; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Methylprednisolone Hemisuccinate; Models, Animal; Sheep; Swine; Transplantation Chimera; Transplantation Tolerance; Transplantation, Heterologous; Transplantation, Heterotopic | 2003 |
Decreased bone mineral density in the pediatric renal transplant population.
Topics: Adolescent; Antibodies, Monoclonal; Basiliximab; Bone Density; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Longitudinal Studies; Male; Methylprednisolone Hemisuccinate; Prednisolone; Prospective Studies; Recombinant Fusion Proteins; Tacrolimus | 2003 |
Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats.
Topics: Animals; Anti-Inflammatory Agents; Aryl Hydrocarbon Hydroxylases; Cyclosporine; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Half-Life; Immunosuppressive Agents; Injections, Intravenous; Male; Metabolic Clearance Rate; Methylprednisolone Hemisuccinate; Oxidoreductases, N-Demethylating; Rats; Rats, Sprague-Dawley | 2004 |
Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile; Biological Availability; Cyclosporine; Cytochrome P-450 CYP3A; Drug Interactions; Drug Therapy, Combination; Immunosuppressive Agents; Injections, Intravenous; Intestinal Absorption; Intestine, Small; Male; Methylprednisolone Hemisuccinate; Oxidoreductases, N-Demethylating; Prodrugs; Pulse Therapy, Drug; Rats; Rats, Sprague-Dawley | 2004 |
Treatment of refractory thrombotic thrombocytopenic purpura using multimodality therapy including splenectomy and cyclosporine.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Combined Modality Therapy; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methylprednisolone Hemisuccinate; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Treatment Outcome | 2009 |
Acute liver failure and aplastic anemia in an 11-year-old girl.
Topics: Acetylcysteine; Anemia, Aplastic; Antilymphocyte Serum; Bilirubin; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Failure, Acute; Methylprednisolone Hemisuccinate; Platelet Transfusion; Prednisone; Transaminases; Treatment Outcome; Vitamin K | 2011 |